Immune Mediated Vaccines

Patients with safe mediated incendiary ailments (for example, IBD, RA or psoriasis, are at increased risk of contamination, in part in light of the malady itself, however for the most part in light of treatment with immunomodulatory or immunosuppressive medications. Regardless of their raised hazard for vaccination preventable disease, immunization scope in IMID patients is shockingly low.

 

  • Vaccines for immunodeficiency diseases
  • Innate immunity and diabetes vaccines
  • Vaccines for autoimmune skin disorders
  • Vaccination strategy in patients with IMID

Related Conference of Immune Mediated Vaccines

March 04-05, 2019

10th Molecular Immunology & Immunogenetics Congress

Barcelona, Spain
March 18-19, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
March 18-19, 2019

13th International Congress on Autoimmunity

Brisbane, Australia
April 15-18, 2019

Annual Immunology Conference 2019

Savannah, USA
June 13-14, 2019 |

10th European Immunology Conference

Berlin, Germany
July 24-25, 2019

11th World Congress and Expo on Immunology

Vancouver, Canada
July 29-30 2019

6th International Conference on Parasitology & Microbiology

Amsterdam, Netherlands
October 21-22, 2019

12th Annual Congress on Immunology & Immunogenetics

Rome, Italy
November 22-23, 2019 |

World Conference on Vaccine and Immunology

Dubai, UAE

Immune Mediated Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in